Edition:
India

Aradigm Corp (ARDM.OQ)

ARDM.OQ on NASDAQ Stock Exchange Capital Market

1.16USD
19 Oct 2018
Change (% chg)

$-0.04 (-3.33%)
Prev Close
$1.20
Open
$1.18
Day's High
$1.23
Day's Low
$1.16
Volume
10,112
Avg. Vol
7,939
52-wk High
$7.26
52-wk Low
$1.04

Chart for

About

Aradigm Corporation is a pharmaceutical company focused on the development and commercialization of products for the treatment and prevention of severe respiratory diseases. The Company's lead product candidate is Pulmaquin inhaled ciprofloxacin, which is in Phase III clinical trials. It offers AERx pulmonary drug delivery... (more)

Overall

Beta: 1.63
Market Cap(Mil.): $55.61
Shares Outstanding(Mil.): 15.11
Dividend: --
Yield (%): --

Financials

Earnings vs. Estimates